NCT03646188 2026-04-16
Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)
SkinJect, Inc.
Phase 1 Terminated
Clinical Trials
11 trialsNCT03737734 2026-04-06
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Active not recruiting
NCT04480645 2026-03-24
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
Phase EARLY_PHASE1 Completed
NCT04066504 2026-03-18
NISSO
Sun Pharmaceutical Industries Limited
Completed
NCT07227350 2026-03-10
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Philogen S.p.A.
Phase 2 Not yet recruiting
NCT06919809 2026-03-09
Effectiveness and Safety of X A-DERMâ„¢ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
McGuire Institute
Phase NA Completed
NCT07227870 2026-03-09
L19IL2/TNF in Patients With Basal Cell Carcinoma
Philogen S.p.A.
Phase 2 Not yet recruiting
NCT04349436 2026-02-27
ARTACUS
Replimune Inc.
Phase 1/2 Recruiting
NCT07428941 2026-02-24
LegitHealth PH
AI Labs Group S.L
Completed
NCT06422936 2026-01-26
SPOTLIGHT204
Highlight Therapeutics
Phase 2 Active not recruiting
NCT03889912 2026-01-21
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
Regeneron Pharmaceuticals
Phase 1 Completed